Population-Based CD4 Counts in a Rural Area in South Africa with High HIV Prevalence and High Antiretroviral Treatment Coverage

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Malaza, Abraham ^a   Mossong, Joël ^a   Bärnighausen, Till ^a,b   Viljoen, Johannes ^a   Newell, Marie Louise ^a,c  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ADULT; AGED; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; CHRONIC DISEASE; DISEASE SURVEILLANCE; EDUCATIONAL STATUS; FEMALE; HEALTH STATUS; HOUSEHOLD; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION RESEARCH; RURAL AREA; SELF REPORT; SOCIAL STATUS; SOUTH AFRICA; TREATMENT DURATION; TREATMENT RESPONSE; TUBERCULOSIS; URBAN AREA;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIMALS; BRAIN MAPPING; CASE-CONTROL STUDIES; CELL PHYSIOLOGICAL PHENOMENA; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; GLUCOSE; HUMANS; LONGITUDINAL STUDIES; MALE; MICE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEURAL NETWORKS (COMPUTER); NEUROIMAGING; POSITRON-EMISSION TOMOGRAPHY; RATS;

EID: 84880753562     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070126     Document Type: Article

References (51)

1. Levy JA, (1993) HIV pathogenesis and long-term survival. AIDS 7: 1401-1410.
2. Gottlieb GS, Sow PS, Hawes SE, Ndoye I, Redman M, et al. (2002) Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa. J Infect Dis 185: 905-914.
3. World Health Organization website. Available: http://www.who.int/hiv/pub/arv/rapid_advice_art.pdf. Accessed 2013 June 24.
4. Cozzi Lepri A, Phillips AN, d'Arminio Monforte A, Castelli F, Antinori A, et al. (2001) When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study. AIDS 15: 983-990.
5. Williams BG, Korenromp EL, Gouws E, Schmid GP, Auvert B, et al. (2006) HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations. J Infect Dis 194: 1450-1458.
6. Lisse IM, Poulsen AG, Aaby P, Knudsen K, Dias F, (1996) Serial CD4 and CD8 T-lymphocyte counts and associated mortality in an HIV-2-infected population in Guinea-Bissau. J Acquir Immune Defic Syndr Hum Retrovirol 13: 355-362.
7. Kelly P, Zulu I, Amadi B, Munkanta M, Banda J, et al. (2002) Morbidity and nutritional impairment in relation to CD4 count in a Zambian population with high HIV prevalence. Acta Trop 83: 151-158.
8. Abuye C, Tsegaye A, West CE, Versloot P, Sanders EJ, et al. (2005) Determinants of CD4 counts among HIV-negative Ethiopians: role of body mass index, gender, cigarette smoking, khat (Catha Edulis) chewing, and possibly altitude? J Clin Immunol 25: 127-133.
9. Kassu A, Tsegaye A, Petros B, Wolday D, Hailu E, et al. (2001) Distribution of lymphocyte subsets in healthy human immunodeficiency virus-negative adult Ethiopians from two geographic locales. Clin Diagn Lab Immunol 8: 1171-1176.
10. Kassa E, Rinke de Wit TF, Hailu E, Girma M, Messele T, et al. (1999) Evaluation of the World Health Organization staging system for HIV infection and disease in Ethiopia: association between clinical stages and laboratory markers. AIDS 13: 381-389.
11. Tsegaye A, Wolday D, Otto S, Petros B, Assefa T, et al. (2003) Immunophenotyping of blood lymphocytes at birth, during childhood, and during adulthood in HIV-1-uninfected Ethiopians. Clin Immunol 109: 338-346.
12. Aina O, Dadik J, Charurat M, Amangaman P, Gurumdi S, et al. (2005) Reference values of CD4 T lymphocytes in human immunodeficiency virus-negative adult Nigerians. Clin Diagn Lab Immunol 12: 525-530.
13. Urassa W, Bakari M, Sandstrom E, Swai A, Pallangyo K, et al. (2004) Rate of decline of absolute number and percentage of CD4 T lymphocytes among HIV-1-infected adults in Dar es Salaam, Tanzania. AIDS 18: 433-438.
14. Bussmann H, Wester CW, Masupu KV, Peter T, Gaolekwe SM, et al. (2004) Low CD4+ T-lymphocyte values in human immunodeficiency virus-negative adults in Botswana. Clin Diagn Lab Immunol 11: 930-935.
15. Klose N, Coulibaly B, Tebit DM, Nauwelaers F, Spengler HP, et al. (2007) Immunohematological reference values for healthy adults in Burkina Faso. Clin Vaccine Immunol 14: 782-784.
16. Mandala WL, MacLennan JM, Gondwe EN, Ward SA, Molyneux ME, et al. (2010) Lymphocyte subsets in healthy Malawians: implications for immunologic assessment of HIV infection in Africa. Journal of Allergy and Clinical Immunology 125: 203-208.
17. Mair C, Hawes SE, Agne HD, Sow PS, N'Doye I, et al. (2008) Factors associated with CD4 lymphocyte counts in HIV-negative Senegalese individuals. Clin Exp Immunol 151: 432-440.
18. Lovvorn AE, Patnaik P, Walker CJ, Kwok C, Van Der Pol B, et al. (2010) Variations in CD4 cell counts among HIV-uninfected and infected women in Uganda and Zimbabwe. International Journal of STD and AIDS 21: 342-345.
19. Urassa WK, Lyamuya EF, Mbena E, Kagoma C, Bredberg Raden U, et al. (1996) Immunohaematological findings in healthy and HIV-1 infected adults in Dar es Salaam, Tanzania. East Afr Med J 73: 670-674.
20. Oladepo DK, Idigbe EO, Audu RA, Inyang US, Imade GE, et al. (2009) Establishment of reference values of CD4 and CD8 lymphocyte subsets in healthy Nigerian adults. Clin Vaccine Immunol 16: 1374-1377.
21. Ngowi BJ, Mfinanga SG, Bruun JN, Morkve O, (2009) Immunohaematological reference values in human immunodeficiency virus-negative adolescent and adults in rural northern Tanzania. BMC Infect Dis 9: 1.
22. Tugume SB, Piwowar EM, Lutalo T, Mugyenyi PN, Grant RM, et al. (1995) Hematological reference ranges among healthy Ugandans. Clin Diagn Lab Immunol 2: 233-235.
23. Zekeng L, Sadjo A, Meli J, Kaptue L, Mpoudi Ngole E, et al. (1997) T lymphocyte subset values among healthy Cameroonians. J Acquir Immune Defic Syndr Hum Retrovirol 14: 82-83.
24. Lawrie D, Coetzee LM, Becker P, Mahlangu J, Stevens W, et al. (2009) Local reference ranges for full blood count and CD4 lymphocyte count testing. S Afr Med J 99: 243-248.
25. Adoga MP, Pennap GR, John PA, Shawulu PT, Kaba SV, et al. (2012) CD4- and CD3-T lymphocyte reference values of immunocompetent urban and rural subjects in an African nation. Scandinavian Journal of Immunology 76: 33-38.
26. Lugada ES, Mermin J, Kaharuza F, Ulvestad E, Were W, et al. (2004) Population-based hematologic and immunologic reference values for a healthy Ugandan population. Clinical and Diagnostic Laboratory Immunology 11: 29-34.
27. Auvert B, Males S, Puren A, Taljaard D, Carael M, et al. (2004) Can highly active antiretroviral therapy reduce the spread of HIV?: A study in a township of South Africa. J Acquir Immune Defic Syndr 36: 613-621.
28. Clerici M, Butto S, Lukwiya M, Saresella M, Declich S, et al. (2000) Immune activation in Africa is environmentally-driven and is associated with upregulation of CCR5. Italian-Ugandan AIDS Project. AIDS 14: 2083-2092.
29. Aldrich J, Gross R, Adler M, King K, MacGregor RR, et al. (2000) The effect of acute severe illness on CD4+ lymphocyte counts in nonimmunocompromised patients. Archives of Internal Medicine 160: 715-716.
30. Tollerud DJ, Clark JW, Brown LM, Neuland CY, Pankiw-Trost LK, et al. (1989) The influence of age, race, and gender on peripheral blood mononuclear-cell subsets in healthy nonsmokers. J Clin Immunol 9: 214-222.
31. Maini MK, Gilson RJ, Chavda N, Gill S, Fakoya A, et al. (1996) Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men. Genitourin Med 72: 27-31.
32. Karcher H, Bohning D, Downing R, Mashate S, Harms G, (2006) Comparison of two alternative methods for CD4+ T-cell determination (Coulter manual CD4 count and CyFlow) against standard dual platform flow cytometry in Uganda. Cytometry B Clin Cytom 70: 163-169.
33. Bekele Y, Mengistu Y, de Wit TR, Wolday D, (2011) Timing of blood sampling for CD4 T-cell counting influences HAART decisions. Ethiop Med J 49: 187-197.
34. Tanser F, Hosegood V, Bärnighausen T, Herbst K, Nyirenda M, et al. (2008) Cohort Profile: Africa Centre Demographic Information System (ACDIS) and population-based HIV survey. Int J Epidemiol 37: 956-962.
35. Zuch M, Mason-Jones AJ, Mathews C, Henley L, (2012) Changes to the law on consent in South Africa: implications for school-based adolescent sexual and reproductive health research. BMC Int Health Hum Rights 12: 3.
36. Bärnighausen T, Tanser F, Malaza A, Herbst K, Newell ML, (2012) HIV status and participation in HIV surveillance in the era of antiretroviral treatment: a study of linked population-based and clinical data in rural South Africa. Tropical Medicine and International Health 17: e103-110.
37. Houlihan CF, Bland RM, Mutevedzi PC, Lessells RJ, Ndirangu J, et al. (2011) Cohort profile: Hlabisa HIV treatment and care programme. Int J Epidemiol 40: 318-326.
38. Yu LM, Easterbrook PJ, Marshall T, (1997) Relationship between CD4 count and CD4% in HIV-infected people. Int J Epidemiol 26: 1367-1372.
39. Malaza A, Mossong J, Bärnighausen T, Newell ML, (2012) Hypertension and Obesity in Adults Living in a High HIV Prevalence Rural Area in South Africa. PLoS One 7: e47761.
40. Nicastri E, Angeletti C, Palmisano L, Sarmati L, Chiesi A, et al. (2005) Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy. AIDS 19: 577-583.
41. Mutevedzi PC, Lessells RJ, Heller T, Bärnighausen T, Cooke GS, et al. (2010) Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes? Bull World Health Organ 88: 593-600.
42. Cornell M, Schomaker M, Garone DB, Giddy J, Hoffmann CJ, et al. (2012) Gender Differences in Survival among Adult Patients Starting Antiretroviral Therapy in South Africa: A Multicentre Cohort Study. PLoS medicine 9: e1001304.
43. Lessells R, Mutevedzi PC, Iwuji C, Newell ML Reduction in early mortality on antiretroviral therapy for adults in rural South Africa since change in CD4+ cell count eligibility criteria. JAIDS (in press).
44. Julg B, Poole D, Ghebremichael M, Castilla C, Altfeld M, et al. (2012) Factors predicting discordant virological and immunological responses to antiretroviral therapy in HIV-1 clade C infected Zulu/Xhosa in South Africa. PLoS One 7: e31161.
45. Messele T, Rinke de Wit TF, Brouwer M, Aklilu M, Birru T, et al. (2001) No difference in in vitro susceptibility to HIV type 1 between high-risk HIV-negative Ethiopian commercial sex workers and low-risk control subjects. AIDS Research and Human Retroviruses 17: 433-441.
46. Olgiati A, Bärnighausen T, Newell ML, (2012) Do self-assessments of health predict future mortality in rural South Africa? The case of KwaZulu-Natal in the era of antiretroviral treatment. Tropical Medicine and International Health 17: 844-853.
47. Westerman LE, Kohatsu L, Ortiz A, McClain B, Kaplan J, et al. (2010) A quality management systems approach for CD4 testing in resource-poor settings. American Journal of Clinical Pathology 134: 556-567.
48. Lawn SD, Myer L, Edwards D, Bekker LG, Wood R, (2009) Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS 23: 1717-1725.
49. Crampin AC, Mwaungulu FD, Ambrose LR, Longwe H, French N, (2011) Normal Range of CD4 Cell Counts and Temporal Changes in Two HIVNegative Malawian Populations. Open AIDS J 5: 74-79.
50. Zeh C, Amornkul PN, Inzaule S, Ondoa P, Oyaro B, et al. (2011) Population-based biochemistry, immunologic and hematological reference values for adolescents and young adults in a rural population in Western Kenya. PLoS One 6: e21040.
51. Levin A, Brubaker G, Shao JS, Kumby D, O'Brien TR, et al. (1996) Determination of T-lymphocyte subsets on site in rural Tanzania: results in HIV-1 infected and non-infected individuals. Int J STD AIDS 7: 288-291.